James R. Kasinger
General Counsel and Secretary · CRISPR Therapeutics AG
- 2024
- Oct 8, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James R. Kasinger files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Samarth Kulkarni - $10.47M in CRSP purchases and sales in the last 12 months
- Raju Prasad - $5.10M in CRSP purchases and sales in the last 12 months
- Naimish Patel - $412K in CRSP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James R. Kasinger?
James R. Kasinger is a corporate insider, tracked as General Counsel and Secretary of CRISPR Therapeutics AG (CRSP). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has James R. Kasinger submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has James R. Kasinger been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($1.44M) across all tracked filings.
